Kura Oncology, Inc.
KURA
Antonio Gualberto
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Antonio Gualberto
The proxy statement of Kura Oncology, Inc. reports total compensation of $2,050,193 for Antonio Gualberto in fiscal 2019, including a base salary of $431,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kura Oncology, Inc. (KURA)
Proxy statement
Start not stated–2020-04-28
Last confirmed by a filing; no departure on record
-
Kura Oncology, Inc. (KURA)
Proxy statement
Start not stated–2020-02-07
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Kura Oncology, Inc. (KURA) | M.D., Ph.D. Former Head of Development and Chief Medical Officer | $431,000 | $2,050,193 |
| 2018 | Kura Oncology, Inc. (KURA) | M.D., Ph.D. Former Head of Development and Chief Medical Officer | $415,000 | $2,021,923 |
| 2017 | Kura Oncology, Inc. (KURA) | M.D., Ph.D. Former Head of Development and Chief Medical Officer | $393,100 | $1,258,058 |
Recent activity
No call appearances or filed executive changes recorded yet.